Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2005
09/15/2005WO2005085845A1 Method for the multidimensional detection of aberrant phenotypes in neoplastic cells to be used to monitor minimal disease levels using flow cytometry
09/15/2005WO2005085844A1 Method of evaluating the transprency and moisture retention of horny layer by using oxidized protein in the horny layer as indication
09/15/2005WO2005085843A1 Method of in vivo inspection of fat soluble vitamin and/or fat soluble food factor through saliva analysis
09/15/2005WO2005085841A1 Method and device for controlling the positioning of a biological element on a support
09/15/2005WO2005085840A1 Handheld apparatus for analysis with a conveyance path for test elements
09/15/2005WO2005085839A1 Fluid formulation evaluation and improvement utilizing broad spectrum impedance spectroscopy
09/15/2005WO2005085838A2 Computational analysis of mass spectroscopic lipid data
09/15/2005WO2005085837A1 Pressure reduction apparatus and method
09/15/2005WO2005085836A1 Method and device for characterizing osi materials
09/15/2005WO2005085829A1 Field effect transistor for measuring biocomponents
09/15/2005WO2005085824A1 Liquid electrolyte gas sensor comprising rigid porous electrode support
09/15/2005WO2005085819A1 In situ fluid condition monitoring
09/15/2005WO2005085818A2 Method and device for the measurement and on-line characterisation of a biomass
09/15/2005WO2005085806A1 Recognition chip for target substance, and detection method and device for the same
09/15/2005WO2005085805A1 Triboacoustic sensor
09/15/2005WO2005085801A1 Method and apparatus for detection of biomolecular interaction using near-field light
09/15/2005WO2005085796A2 System and method for integrating fluids and reagents in self-contained cartridges containing sensor elements
09/15/2005WO2005085793A1 Device and method for determining the mass emission of at least one exhaust gas component in a vehicle situated in traffic
09/15/2005WO2005085472A2 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
09/15/2005WO2005085469A2 Diagnostics and therapeutics for diseases associated with rho-associated protein kinase 1 (rock1)
09/15/2005WO2005085466A2 Diagnostic and therapeutics for diseases associated with rho-associated protein kinase 2 (rock2)
09/15/2005WO2005085439A1 Probes for detecting protein nuclear migration and method of detecting and quantifying protein nuclear migration using the same
09/15/2005WO2005085438A1 Transgenic nonhuman mammal representing the pathologic conditions of human rheumatoid arthritis
09/15/2005WO2005085436A1 Method of detecting carcinogenesis caused by hepatitis b virus
09/15/2005WO2005085433A1 Method of regulating o-glycosylation in eucaryotic cell
09/15/2005WO2005085427A1 Rat embryonic stem cell
09/15/2005WO2005085423A1 Oct-4 and gjic expression as markers for adult human stem cells and cancer cell precursors
09/15/2005WO2005085416A1 Method of screening fungus-specific antimicrobial agent and kit therefor
09/15/2005WO2005085412A2 Method and device for the measurement and characterisation of a biomass, application thereof in relation to on-line biomass data measuring in a fermentation process and associated control method
09/15/2005WO2005085292A2 Method for detecting the activatable free form of psa and the use thereof for diagnosing benign pathologies of the prostate and adenocarcinoma of the prostate
09/15/2005WO2005085290A1 Anti fk778antibodies and high sensitive immunoassay methods
09/15/2005WO2005085289A1 Specific monoclonal and polyclonal antibodies for repinotan and the open ring form thereof
09/15/2005WO2005085269A1 Nucleotide derivatives and dna microarray
09/15/2005WO2005085263A1 Molecular spacer, production method thereof and uses of same on an analysis chip with molecules or biomolecules
09/15/2005WO2005085193A1 Fluorescent chelates
09/15/2005WO2005084707A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like
09/15/2005WO2005084547A1 System and method for automatic taking of fluid samples
09/15/2005WO2005084534A1 Personal diagnostic devices and related methods
09/15/2005WO2005084527A1 Joint-diagnostic in vivo & in vitro apparatus
09/15/2005WO2005084429A1 Method of constructing animal having cancer cells transplanted thereinto
09/15/2005WO2005084404A2 Microfluidic biosensor and methods of use
09/15/2005WO2005084374A2 Magnetic device for isolation of cells and biomolecules in a microfluidic environment
09/15/2005WO2005084369A2 Arrays of colloidal crystals
09/15/2005WO2005084283A2 Supersensitive immunoassays
09/15/2005WO2005084278A2 Methods for identifying or screening for agents that modulate 17beta- hsd3
09/15/2005WO2005084266A2 Functional method for generating or screening for ligands which modulate steroid hormone receptors
09/15/2005WO2005084223A2 Methods and compositions for hair growth
09/15/2005WO2005084210A2 Multiplex detection probes
09/15/2005WO2005084194A2 Methods of evaluating efficacy of an immune response by assessing alpha-1 integrin expression
09/15/2005WO2005084193A2 Method for identifying a site of protein-protein interaction for the rational design of short peptides that interfere with that interaction
09/15/2005WO2005084109A2 Cancer specific gene mh15
09/15/2005WO2005084103A2 Method for detecting neoplastic disorders in a solubilized body sample
09/15/2005WO2005071394A8 Electrode system for an electrochemical sensor
09/15/2005WO2005067405A3 Method for screening responsiveness to drugs effective in treatment or prevention of vitiligo and method for prognosis of vitiligo
09/15/2005WO2005059037B1 Reagent for detecting an analyte
09/15/2005WO2005057209A3 Sample age monitoring devices and methods
09/15/2005WO2005056817A3 Method for recovering microorganisms from a sample
09/15/2005WO2005056759A3 Methods of generating variant proteins with increased host string content and compositions thereof
09/15/2005WO2005056569A3 Beta integrin gene and protein
09/15/2005WO2005055925A8 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
09/15/2005WO2005055812A3 Serum biomarkers for chagas disease
09/15/2005WO2005052118A3 Method for identifying androgen receptor modulators with full or mixed agonist activity
09/15/2005WO2005049856A3 Methods and apparatus for the rapid detection of microorganisms collected from infected sites
09/15/2005WO2005049084A3 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure
09/15/2005WO2005047898A3 Methods and compositions for identifying therapeutic compounds
09/15/2005WO2005046711A3 Stimulation or inhibition of gamma delta t-cells to promote or inhibit bone healing
09/15/2005WO2005045437A3 Method for distinguishing immunologically defined all subtypes
09/15/2005WO2005045396A3 Use of particulate labels in bionalyte detection methods
09/15/2005WO2005044077A3 Assay for acetyltransferases and acetyltransferase substrates
09/15/2005WO2005043167A3 Method for distinguishing aml subtypes with differents gene dosages
09/15/2005WO2005040802A3 Cylin binding peptides, and their use in drug screening assays
09/15/2005WO2005038465A3 Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors
09/15/2005WO2005038459A3 Bridged element for detection of a target substance
09/15/2005WO2005037189A3 Cytoplasmic activity of retinoid x receptor and its regulation by ligands and dimerization
09/15/2005WO2005036168A3 Method of detecting biological materials in liquid
09/15/2005WO2005031350A3 Human protein acyl transferases and methods of uses therefor
09/15/2005WO2005030040A3 Hematopoietic stem cell identification and isolation
09/15/2005WO2005029091A3 Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
09/15/2005WO2005029088A3 Diagnostic method for brain damage-related disorders
09/15/2005WO2005029076A3 Nanoparticle conjugates and method of production thereof
09/15/2005WO2005028676A3 Method of diagnosing breast cancer
09/15/2005WO2005028506A3 Crystal structure of fms-like tyrosine kinase
09/15/2005WO2005019249A3 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
09/15/2005WO2005015161A3 Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation
09/15/2005WO2005012482A3 Assay for identification of bioactive compounds that interact with heat shock protein 90
09/15/2005WO2005010482A9 Detection of biomarkers
09/15/2005WO2005010151A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/15/2005WO2005008557B1 The method of conducting and interpretation of clinical trials
09/15/2005WO2005005611A3 Crystals and structures of protein kinase chk2
09/15/2005WO2005003720A3 Method of detecting the cystic fibrosis transmembrane conductance regulator (cftr) at cell exterior
09/15/2005WO2005000099A3 BLOOD FACTOR DOMAINS (BFDs)
09/15/2005WO2004089284A3 Targets for tumor growth inhibition
09/15/2005WO2004084823A3 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
09/15/2005WO2004084711A3 Methods of detecting neurological disorders
09/15/2005WO2004083449A3 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
09/15/2005WO2004064770A3 Use of smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney
09/15/2005WO2004020586A3 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
09/15/2005WO2004016644A3 Compositions and methods used for identifying factors required for the agglomeration of proteins
09/15/2005WO2003101400A3 Cancer-linked gene as target for chemotherapy
09/15/2005WO2003083060A3 Crystals and structures of mst3
1 ... 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 ... 3937